RxDoctor Payments Data

Antonio Martinez, MD

Anatomic Pathology & Clinical Pathology · West Des Moines, IANPI 1316971047

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $35,580 of the $58,299 with a category attached, or 61.0%. Gilead accounts for 99.7% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $33,584 and has fallen 64.2% since, to $12,029 in 2023. Among anatomic pathology & clinical pathology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$58,299in general payments, 2019–2025

Across 36 payments — averaging $1619.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$58K
  • Genentech USA, Inc.$116
  • Roche Diagnostics Corporation$75

What the payments were for

  • Consulting fees$11,72020%
  • Speaking & faculty fees$35,58061%
  • Travel & lodging$10,09717%
  • Food & beverage$9022%

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead31$58,108
Genentech USA, Inc.1$116
Roche Diagnostics Corporation4$75

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$58,299 in reported general payments places this provider in the 95th percentile of 46 anatomic pathology & clinical pathology providers in Iowa.

See all anatomic pathology & clinical pathology providers in Iowa

Medicare billing

Part B allowed, 2024
$449,836
Medicare patients
2,294
Services billed
7,676

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →